Caverject and nervousness Patient Reports February 10, 2012

Caverject Side Effects Report #5774362-7
Caverject side effect was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2008. Male patient, weighting 194.4 lb, was diagnosed with erectile dysfunction  and was treated with Caverject. After drug was administered, patient experienced the following side effects: device malfunction, hypertension, nervousness. Caverject dosage: unknown. During the same period patient was treated with FLOMAX. Patient recovered.

Caverject Side Effects Report #5934632-6
Caverject side effect was reported by a Consumer or non-health professional from BRAZIL on Oct 17, 2008. Male patient, weighting 187.4 lb, was diagnosed with erectile dysfunction  and was treated with Caverject. After drug was administered, patient experienced the following side effects: application site erythema, blood cholesterol increased, nervousness. Caverject dosage: unknown. During the same period patient was treated with SIMVASTATIN, AMLODIPINE, ATENOLOL, RANITIDINE HYDROCHLORIDE. Patient recovered.

Caverject Side Effects Report #5941219-8
Caverject side effect was reported by a Consumer or non-health professional from BRAZIL on Oct 24, 2008. Male patient, weighting 187.4 lb, was diagnosed with erectile dysfunction  and was treated with Caverject. After drug was administered, patient experienced the following side effects: application site erythema, blood cholesterol increased, nervousness. Caverject dosage: unknown. During the same period patient was treated with SIMVASTATIN, AMLODIPINE, ATENOLOL, RANITIDINE HYDROCHLORIDE. Patient recovered.

Caverject Side Effects Report #4694068-5
Caverject side effect was reported by a Physician from on June 03, 2005. Male patient was diagnosed with erectile dysfunction  and was treated with Caverject. After drug was administered, patient experienced the following side effects: blood cholesterol increased, depression , nervousness, sleep disorder . Caverject dosage: 7.5 MG. During the same period patient was treated with CLOPIDOGREL BISULPHATE, METFORMIN, PIOGLITAZONE, GLIPIZIDE, SULINDAC, FUROSEMIDE, ISOSORBIDE MONONITRATE, ENALAPRIL MALEATE. Patient was hospitalized. Patient recovered.